APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 249 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $198,569 | -98.5% | 5,220 | -96.4% | 0.04% | -98.2% |
| Q2 2023 | $13,105,555 | +15.2% | 143,859 | -16.6% | 2.18% | -0.1% |
| Q1 2023 | $11,377,440 | +44.4% | 172,490 | +13.2% | 2.19% | +43.5% |
| Q4 2022 | $7,877,501 | -7.0% | 152,340 | +22.9% | 1.52% | -8.6% |
| Q3 2022 | $8,469,000 | +22.2% | 123,990 | -19.1% | 1.67% | +19.5% |
| Q2 2022 | $6,930,000 | +96.3% | 153,250 | +120.5% | 1.40% | +122.6% |
| Q1 2022 | $3,531,000 | -5.0% | 69,500 | +6.9% | 0.63% | +139.3% |
| Q4 2020 | $3,718,000 | -85.2% | 65,000 | -91.5% | 0.26% | -88.6% |
| Q2 2020 | $25,103,000 | +147.3% | 768,609 | +102.8% | 2.30% | +18.2% |
| Q1 2020 | $10,151,000 | -27.2% | 378,923 | -16.8% | 1.95% | -6.3% |
| Q4 2019 | $13,944,000 | -41.9% | 455,393 | -54.3% | 2.08% | -49.8% |
| Q3 2019 | $24,017,000 | -36.4% | 996,983 | -33.1% | 4.14% | -8.2% |
| Q2 2019 | $37,756,000 | +12.1% | 1,489,957 | -13.8% | 4.52% | +11.4% |
| Q1 2019 | $33,693,000 | +17.8% | 1,727,829 | -20.3% | 4.05% | +4.3% |
| Q4 2018 | $28,597,000 | -21.1% | 2,168,115 | +6.4% | 3.89% | +1.0% |
| Q3 2018 | $36,245,000 | -5.5% | 2,038,516 | +17.0% | 3.85% | -10.2% |
| Q2 2018 | $38,338,000 | +5.2% | 1,742,622 | +5.8% | 4.29% | +7.3% |
| Q1 2018 | $36,430,000 | -4.2% | 1,647,692 | -6.0% | 3.99% | -16.0% |
| Q4 2017 | $38,033,000 | – | 1,752,655 | – | 4.75% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
| Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
| Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
| Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
| Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
| ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
| Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
| Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
| venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
| HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |